Scientific Research News
News about theoretical and practical scientific research spanning a wide variety of disciplines, including engineering, computer science, biology, physics and chemistry. Includes information about research facilities, funding, resources and public policy.
ALS TDI Launches ALS Trial Navigator: A Revolutionary Platform to Simplify Access to Clinical Trials
The ALS Therapy Development Insitute (ALS TDI) has announced the beta launch of the ALS Trial Navigator. This innovative set of tools is designed to guide people with ALS and caregivers through the process of finding and understanding ALS clinical trials – with the ultimate goal of personalizing the search process and helping users make informed decisions about participation in trials. - February 29, 2024 - ALS Therapy Development Institute
ABA Tech Awarded: Top Corporate Training Company
ABA Technologies, Inc. (ABA Tech) is pleased to announce its designation as a Top 10 Online Corporate Training Company for 2023 by Manage HR, an institution whose mission entails embracing strategic roles for customers and using talent to drive business value to customers. ABA Technologies... - February 24, 2024 - ABA Technologies, Inc.
The Oaklea Press Releases a Book Announcing the End of Secular Humanism as a Viable Philosophy
A bestselling author’s new book just published by Oaklea Press cites the work of 33 individuals that he says taken together show that the philosophy of Secular Humanism, aka Physicalism, and Scientific Materialism, do not hold up to scrutiny. - February 19, 2024 - The Oaklea Press
Gotham Biotech’s Histoplasma Urinary Antigen EIA Kit Now Available for Purchase as Histoplasma Spreads in the U.S.
Histoplasmosis is a systemic disease caused by the thermally dimorphic fungus Histoplasma capsulatum. H. capsulatum is distributed worldwide and endemic to the Ohio and Mississippi River Valleys, where the CDC estimates 60% to 90% of people who live in the region have been exposed to the fungus at some point during their life, and to certain regions of Central and South America. Medicare records from 2007 to 2016 have found cases of histoplasmosis have now spread to 47 states and Washington, DC. - February 15, 2024 - Gotham Biotech
Bench International and Deloitte Launch the "Bench and Deloitte Life Sciences Tech Innovation Award" to Celebrate Outstanding Women in Life Sciences
First-ever award to be presented on March 14, during LAMedTechWeek, at BioscienceLA. - February 13, 2024 - Bench International
Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report
Sponsor Outsourcing Dollars May Shift to Clinical Site Networks, Transforming the CRO Relationship - February 13, 2024 - Life Science Strategy Group, LLC
Creative Diagnostics Announces New AAV Reagent Solutions for Gene Therapy
Creative Diagnostics has announced its extensive portfolio of AAV Reagent Solutions to support researchers. - February 04, 2024 - Creative Diagnostics
Patient Experience and Satisfaction with Electronic Consent, Onboarding, and Diaries in Clinical Trials Report
New Market Research Shows Different Patient Preferences for Electronic Diaries - January 31, 2024 - Life Science Strategy Group, LLC
Creative Diagnostics Announces MDT Services for Measuring Antibacterial Effectiveness
Creative Diagnostics has announced new Minimum Doubling Time (MDT) services to measure the effectiveness of antibacterial compounds. - January 26, 2024 - Creative Diagnostics
Space Lab® Selected by NASA to Develop EcoMine™ − A Bioregenerative Mineral Mining Facility for the Moon
Space Lab® has announced that the company has been selected to develop EcoMine™, a closed-loop bioregenerative mining facility for the moon, through the NASA Small Business Innovation Research (SBIR) Ignite program. NASA’s plans to establish a sustained Lunar presence for scientific... - January 25, 2024 - Space Lab Technologies, LLC
Impact of the In Vitro Diagnostic Regulation on Clinical Trials in the EU and CRO Outsourcing Report
IVDR Delays Driving Trial Sponsors to Actively Seek Alternative Site and CRO Outsourcing Strategies - January 17, 2024 - Life Science Strategy Group, LLC
TrialX Partners with The Michael J. Fox Foundation to Power Its Parkinson’s Clinical Trial Finder
To increase accessibility of information for individuals and families affected by Parkinson’s disease. - January 08, 2024 - TrialX
FF Biotherapeutics Announces Search for Angel Investment to Revolutionize Immunotherapy and Vaccine Development
FF Biotherapeutics, a pioneering biotech startup at the forefront of immunotherapy and vaccine development, today announced its active pursuit of Angel investment. This critical funding round aims to propel the development of its groundbreaking Synthetic Standardized Convalescent Plasma (SSCP) and... - November 29, 2023 - FF Biotherapeutics
Huntington Study Group® Holds 30th Annual Meeting
The Huntington Study Group® (HSG®), a world leader in conducting clinical trials and providing educational programming for Huntington’s disease (HD), recently held its 30th annual meeting, HSG 2023, November 2-4 in Phoenix, AZ. Hundreds of scientists, industry partners, HSG research... - November 21, 2023 - Huntington Study Group
Topsarge Patents a Scientific Model for Personnel Development Studies
Topsarge Business Solutions (TBS) of Temple Texas, has successfully submitted a utility patent for a Blended Community Science model for Personnel Development. Principal Investigator Daniel K. Elder and Research Director Dr. David Litteral are credited with inventing this hybrid method for public... - November 09, 2023 - Topsarge Business Solutions LLC
Successful Human Factors™ Unveils Services Addressing Project Delays and High FDA Failure Rates in MedTech
Notably, FDA data revealed alarmingly high failure rates in Human Factors (HF) submissions (as high as 96.1%). Leading the charge in optimizing HF projects in MedTech product development, Successful Human Factors™ unveils innovative, purpose-fit services. - October 25, 2023 - Successful Human Factors™
Thrombolex Announces Significant New Insights from the RESCUE Trial with the BASHIR™ Endovascular Catheter
Thrombolex, Inc., announced never-before-reported major reductions in obstruction in all of the segmental pulmonary arteries (PA), based on independent core lab data analysis of 107 patients from 18 sites in the USA, with acute intermediate-risk pulmonary embolism (PE), using the BASHIR™ Endovascular Catheter and small doses of tPA. The RESCUE trial also showed unsurpassed efficacy and safety in this patient population compared to recently published studies with other FDA-cleared devices. - October 24, 2023 - Thrombolex, Inc.
Huntington Study Group® Observational Pilot Study Shows HSG’s myHDstory® Platform Reaches the Unreachable
The Huntington Study Group® (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc. (HSGCR), a world leader in conducting clinical trials for Huntington’s disease (HD), today announces that the pilot observational study on their innovative online direct-to-patient... - October 16, 2023 - Huntington Study Group
Creative Diagnostics Launches New Azaperone Test Reagents for Research Applications
Creative Diagnostics has announced the release of its new line of Azaperone Test Reagents. - October 15, 2023 - Creative Diagnostics
knowRX Strengthens Platform to Support Physician Engagement in Clinical Trial Diversity
knowRX, a clinical trial solutions provider, has launched an Investigator/Provider Learning Center on its PIXS™ platform, focusing on "Cultural Considerations in the Conduct of Clinical Trials." This initiative aims to educate physicians, increasing their awareness and understanding of clinical trials. The goal is to bridge gaps in patient access and awareness, particularly among underrepresented populations, aligning with recent FDA guidelines emphasizing diversity in clinical trials. - October 07, 2023 - knowRX, Inc.
Cayman Chemical Introduces a New Tool to Study Protein-Lipid Interactions
Cayman LipiDOT Strips™ are a simple tool for the rapid identification of protein-lipid interactions. Researchers can screen a protein of interest against 22 biologically relevant lipids in one assay in a single day at a lower price compared with existing commercial options. - October 04, 2023 - Cayman Chemical Company
GeneProof Announces Expansion of Its IVDR-Certified PCR Portfolio
GeneProof, a leader in molecular diagnostics, today announced the addition of six new IVDR-certified PCR kits to its expansive portfolio. This comes as a testament to the company’s dedication to delivering its entire portfolio of approximately 80 products as IVDR compliant by 2027. Currently,... - October 03, 2023 - ALPCO
Max Planck Florida Researcher Receives Prestigious NIH New Innovator Award
Research into the neural mechanisms underlying addiction and eating disorders has earned Max Planck Florida Institute for Neuroscience researcher Dr. Sarah Stern an NIH Director’s New Innovator Award. This award will provide Dr. Stern and MPFI with $2.85 million in research funding support over five years, and is part of the NIH’s High-Risk-High Reward Research Program of the NIH Common Fund. - October 02, 2023 - Max Planck Florida Institute for Neuroscience
Space Research Incubator Addressing Methane Emissions Using Satellite Data Welcomes 20 Teams from Australia, New Zealand, Philippines, New Caledonia and East Timor
SpaceBase today announces the Space for Planet Earth Virtual Research Incubator Teams across the Pacific region. Teams include: High School Level: Methane Mavericks - Melbourne Girls' College and Kyneton High School, Australia EIJC - James Cook International School, Dumbea, New... - September 26, 2023 - SpaceBase Limited
NeVa CLEAR Study Results Presented at ESMINT: Innovative Thrombectomy Device Achieves Notable First-Pass Success and Patient Outcomes
Primary results from the CLEAR Study(1) were presented at the ESMINT annual meeting in Marseille, France (4-6 September 2023), where Vesalio also announced the fifth anniversary of the international commercialization of the NeVa™ device. - September 21, 2023 - Vesalio
Alevea Mental Health Advocates for Psychedelic Therapy, Citing MAPS' Latest Research and Its Own Success with Ketamine Treatment
Alevea Mental Health fully endorses psychedelic therapy as an effective mental health treatment, following the recent publication of MAPS' Phase 3 study on MDMA-assisted therapy for PTSD. Alevea has already reported significant success in alleviating symptoms of anxiety, depression, and PTSD through its own Ketamine treatment programs. CEO Topher Bradshaw expressed astonishment at the remarkable patient improvements, particularly when other treatments had failed. - September 20, 2023 - Alevea Mental Health
Nanocellect Biomedical Welcomes Peter Vander Horn as Senior VP of Research & Development
NanoCellect Biomedical, a leading pioneer in gentle microfluidic cell sorting technologies, is thrilled to announce the addition of Peter Vander Horn, PhD. to their executive team as Senior Vice President of Research & Development. With an illustrious career marked by groundbreaking... - September 19, 2023 - NanoCellect Biomedical
Mission Microwave Announces One-Kilowatt Ku-Band SSPA/BUC for Satellite Gateways and Teleports
Leading manufacturer of Solid State Power Amplifiers announces a one-kilowatt Ku-Band Block Upconverter, enabling teleports and satellite gateways to take advantage of the reliability and efficiency offered by Gallium Nitride (GaN) amplifiers in a compact hub-mount design. - September 12, 2023 - Mission Microwave
Creative Diagnostics Launches Antimicrobial Synergy Testing Services
Creative Diagnostics has recently launched a series of Antimicrobial Synergy Testing Services to the reserch community. - September 06, 2023 - Creative Diagnostics
The Ohio State University to Offer an Online Corrosion Short Course Fall 2023
Gamry Instruments is proud to sponsor an online Corrosion Short Course to be presented by The Ohio State University. The course is scheduled for October 16, 2023 - November 17, 2023. Registration is now open. - August 24, 2023 - Gamry Instruments
MPFI’s Wang Lab Awarded $1M Grant to Study Mechanism Behind Memory Decline in Alzheimer’s
Memory loss is one of the most devastating effects of Alzheimer's disease, yet the mechanisms behind it remain a mystery. MPFI is working to change that through a new $1,038,819 research award from the National Institute on Aging of the NIH. - August 23, 2023 - Max Planck Florida Institute for Neuroscience
Huntington Study Group Welcomes FDA Approval of New Drug for Chorea in Huntington’s Disease
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in clinical trials for Huntington’s disease (HD), today shares that the Phase 3 pivotal KINECT®-HD study conducted by HSG in collaboration with Neurocrine Biosciences,... - August 18, 2023 - Huntington Study Group
Huntington Study Group Announces Positive Topline Results for Virtual Unified Huntington’s Disease Rating Scale® (vUHDRS®) Study
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), today announces positive topline results from its Virtual Unified Huntington’s Disease Rating Scale®... - August 14, 2023 - Huntington Study Group
Gold Sponsor Orbica Supports the Space for Planet Earth Challenge 2023
SpaceBase, a New Zealand based education and consulting social enterprise, announces partnership with Orbica Global Limited. Orbica will be providing the use of their geospatial data platform. AWS, through Orbica will provide cloud compute access. Both organizatons are the latest in-kind sponsors of the Space for Planet Earth Challenge 2023. - August 14, 2023 - SpaceBase Limited
The FOXG1 Research Foundation Appoints Dr. Soo-Kyung Lee as Chief Scientific Officer to Lead Therapeutics for FOXG1 Syndrome, an Autism-related Rare Disease
The FOXG1 Research Foundation (FRF), a parent-led rare disease patient organization focused on driving therapeutics for FOXG1 syndrome, an Autism-related neurological condition, announced today the appointment of Dr. Soo-Kyung Lee as the new Chief Scientific Officer of the FOXG1 Research Foundation (FRF). Dr. Lee’s dedication to curing FOXG1 syndrome is deeply personal as a mother to Yuna, diagnosed with FOXG1 syndrome in 2009. - August 12, 2023 - FOXG1 Research Foundation
Creative Diagnostics Announces New Antimicrobial Susceptibility Testing Services
Creative Diagnostics announced the launch of its new Antimicrobial Susceptibility Testing (AST) services. - August 06, 2023 - Creative Diagnostics
The ALS Therapy Development Institute and Unite Genomics Partner to Integrate Electronic Health Records Into the ALS Research Collaborative
The ALS Therapy Development Institute (ALS TDI) is partnering with Unite Genomics, a leading healthcare data analytics company, to integrate electronic health record (EHR) data into the ALS Research Collaborative (ARC) via Unite Genomics’ state-of-the-art healthcare data access and analytics... - August 02, 2023 - ALS Therapy Development Institute
Huntington Study Group and CHDI Foundation Collaborate on Enroll-HD
HSG Clinical Research, Inc. - the Huntington Study Group’s clinical research organization (CRO) and wholly owned subsidiary (collectively referred to here as HSG) - has begun providing CRO services for CHDI Foundation’s Enroll-HD observational study and clinical research platform in the... - July 25, 2023 - Huntington Study Group
Cayman and Navinci Announce Strategic Partnership, Expanding Access to Next-Generation Tools for Spatial Proteomics
Cayman and Navinci have partnered to bring next-generation proximity ligation-based solutions for spatial proteomics to US and Canada-based researchers. - July 13, 2023 - Cayman Chemical Company
ABA Technologies’ Adam Hockman Receives 2023 SABA Award
Adam Hockman, Chief Learning Architect at ABA Technologies, Inc. (ABA Tech), receives a Public Awareness Grant from the Society for the Advancement of Behavior Analysis (SABA). SABA’s Public Awareness Grant is awarded to projects that are “designed to deliver messaging focused on... - July 12, 2023 - ABA Technologies, Inc.
Creative Diagnostics Introduces qPCR Assay for Rapid Virus Detection and Quantification
Creative Diagnostics has introduced its new qPCR Assay to the research community. - July 07, 2023 - Creative Diagnostics
UserWise, LLC Celebrates Role in Norlase Obtaining 510(k) Clearance and CE Mark Approval
UserWise, LLC, a San Jose-based human factors consultancy, is pleased to announce its instrumental role in obtaining FDA 510(k) clearance and CE Mark approval for the Norlase ECHO™ Green Pattern Laser photocoagulator. UserWise began working with Norlase in 2018 to develop and execute the... - June 23, 2023 - UserWise, LLC
International LabAutomation Day is June 21
Celebrating Lab Automation; Laboratory automation refers to the use of technology, equipment, and software to streamline and optimize laboratory processes and operations. It involves automating repetitive tasks, data collection and analysis, sample handling, and other activities in a laboratory setting. By leveraging various automated systems, laboratories can enhance efficiency, accuracy, reproducibility, and throughput while reducing human error and the time required to perform experiments. - June 20, 2023 - Laboratory Robotics Interest Group (LRIG)
Creative Diagnostics Announces the Launch of Radial Immunodiffusion Testing Service
Creative Diagnostics has launched its new Single Radial Immunodiffusion Testing services for the biological industry. - June 09, 2023 - Creative Diagnostics
Hemanext Announces a Strategic Partnership and Investment from Vitalant
Partnership to include research and development at Vitalant Innovation Center. - June 07, 2023 - Hemanext
PharmStars Announces “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface” Theme for its Fall 2023 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, is accepting applications for its Fall 2023 cohort around the theme “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.” The cohort is open to startups with digital health solutions that pharma can use to innovate therapeutic supply chain management, medication delivery, or the patient-drug experience for small molecules, biologics, or advanced therapies. Applications are due July 10, 2023. - June 06, 2023 - PharmStars
New Research Benchmarks Biopharmaceutical Perceptions of Global CRO Thought Leadership
Landmark Research Analyzes Perspectives of US and EU Biopharma C-Suite, Clinical Operations and Medical/Regulatory Affairs Professionals on Global CRO Thought Leadership. - June 01, 2023 - Life Science Strategy Group, LLC
Huntington Study Group Announces Call for Abstracts for 30th Annual Meeting
The Huntington Study Group (HSG), with a mission of accelerating treatments that make a difference for those impacted by Huntington’s disease, together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease... - June 01, 2023 - Huntington Study Group
Clubhouse International Launches US Advocacy Campaign This Mental Health Awareness Month
Clubhouse International recognizes May as Mental Health Awareness Month by hosting several awareness-raising initiatives including the launch of a US Advocacy and Awareness campaign, Healing Minds, Powering Communities, in partnership with Fountain House NY, and other US advocacy organizations that aims to effect policy change and increase funding for mental health services. - May 25, 2023 - Clubhouse International
Creative Diagnostics Introduces Viral Replicon Assay Service to Support Virology Research
Creative Diagnostics recently introduced a series of Viral Replicon Assay services to assist researchers in identifying and studying viruses. - May 20, 2023 - Creative Diagnostics